Ji-Lin Chen Selected Research

Ji-Lin Chen Research Topics

Disease

21	Myocardial Infarction 11/2016 - 02/2003
18	Thrombosis (Thrombus) 11/2016 - 12/2006
16	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 12/2006
8	Neoplasms (Cancer) 10/2021 - 08/2018
5	Coronary Artery Disease (Coronary Atherosclerosis) 10/2011 - 06/2007
5	Infarction (Infarctions) 09/2010 - 02/2003
5	Death (Near-Death Experience) 03/2009 - 06/2007
4	Hemorrhage 01/2016 - 08/2009
4	Coronary Disease (Coronary Heart Disease) 09/2013 - 07/2008
4	AIDS-Related Complex (ARC) 04/2011 - 07/2008
4	Necrosis 06/2008 - 03/2005
3	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2017
3	Triple Negative Breast Neoplasms 01/2021 - 01/2017
3	Inflammation (Inflammations) 04/2020 - 01/2005
3	Unstable Angina 10/2010 - 03/2007
2	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2018
2	Pathologic Constriction (Stenosis) 01/2020 - 07/2008
2	Diabetes Mellitus 03/2009 - 09/2008
2	Reperfusion Injury 02/2008 - 04/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2008 - 04/2007
2	Atherosclerosis 02/2005 - 01/2005
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 04/2020
1	Carcinogenesis 04/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2015
1	Acute Coronary Syndrome 03/2013
1	Stable Angina 10/2011
1	Rupture 03/2009
1	Hyperlipidemias (Hyperlipidemia) 01/2009
1	No-Reflow Phenomenon 01/2009
1	Hyperglycemia 01/2009
1	Myocardial Reperfusion Injury 02/2008
1	Cicatrix (Scar) 08/2006
1	Coronary Occlusion 03/2005

Drug/Important Bio-Agent (IBA)

13	omega-Chloroacetophenone (Mace)IBA 10/2012 - 12/2006
5	Clopidogrel (Plavix)FDA Link 11/2016 - 02/2005
4	Cytochrome P-450 CYP2C19IBA 11/2016 - 07/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2020 - 03/2007
3	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2019 - 08/2018
3	Sirolimus (Rapamycin)FDA Link 09/2008 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2018
2	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 01/2021 - 04/2020
2	KynurenineIBA 01/2021 - 04/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2019
2	EnzymesIBA 04/2020 - 04/2020
2	Estrogen ReceptorsIBA 08/2018 - 01/2017
2	erucylphosphocholineIBA 09/2010 - 04/2007
2	Phosphates (Orthophosphate)IBA 02/2008 - 04/2007
2	BuffersIBA 02/2008 - 04/2007
2	salicylhydroxamic acid (SHAM)IBA 03/2005 - 02/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Dipyridamole (Persantine)FDA LinkGeneric 04/2020
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 04/2020
1	Mevalonic Acid (Mevalonate)IBA 04/2020
1	CateninsIBA 04/2020
1	Activating Transcription Factor 6IBA 10/2018
1	Tamoxifen FDA LinkGeneric 08/2018
1	Oncogene Proteins (Oncogene Protein)IBA 08/2018
1	palbociclibIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Cytostatic AgentsIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	enzalutamideIBA 01/2017
1	SteroidsIBA 10/2015
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Ligases (Synthetase)IBA 03/2013
1	C-Reactive ProteinIBA 10/2011
1	BESIBA 03/2009
1	Blood Glucose (Blood Sugar)IBA 01/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2008
1	Adenosine (Adenocard)FDA LinkGeneric 06/2008
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2007
1	Trinitrotoluene (TNT)IBA 06/2007
1	CM-DiIIBA 04/2007
1	PKH 26IBA 04/2007
1	Dihydrotachysterol (AT 10)IBA 03/2007
1	Glyburide (Glibenclamide)FDA LinkGeneric 12/2006
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 12/2006
1	Nicorandil (SG 75)IBA 12/2006
1	Metoprolol (Toprol-XL)FDA LinkGeneric 08/2006
1	Atenolol (Tenormin)FDA LinkGeneric 08/2006
1	triphenyltetrazoliumIBA 08/2005
1	Diltiazem (Cardizem)FDA LinkGeneric 03/2005

Therapy/Procedure

20	Stents 11/2016 - 12/2006
6	Drug-Eluting Stents 01/2020 - 07/2008
5	Percutaneous Coronary Intervention 09/2013 - 01/2009
3	Therapeutics 10/2021 - 01/2009
3	Ligation 06/2008 - 03/2005
2	Length of Stay 01/2016 - 10/2010
1	Immunotherapy 10/2021
1	Precision Medicine 10/2021
1	Transplantation 02/2008